NMT Medical, Inc's BioSTAR(R) Receives Canadian Regulatory Approval
BOSTON--(BUSINESS WIRE)--NMT Medical, Inc. (Nasdaq: NMTI) announced today that it has received an HPB (Health Products and Food Branch) medical device license in Canada for its BioSTAR® bioabsorbable septal repair implant technology and Rapid Transport™ delivery system. The approval is required in order to commence commercialization in Canada.